<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098849</url>
  </required_header>
  <id_info>
    <org_study_id>RBT_10</org_study_id>
    <nct_id>NCT03098849</nct_id>
  </id_info>
  <brief_title>Effectiveness of a Buteyko-based Breathing Technique for Asthma Patients</brief_title>
  <official_title>Effectiveness of a Buteyko-based Breathing Technique on Psycho-physiological Parameters of Adults With Asthma - a Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ARCIM Institute Academic Research in Complementary and Integrative Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ARCIM Institute Academic Research in Complementary and Integrative Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effects of a Buteyko-based breathing
      technique on physiological and psychological parameters in adults with asthma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators explore the effects of a Buteyko-based breathing technique training using a
      treatment group vs. control group design and a repeated measures design with follow-up
      measurements 3 and 6 months after the intervention. The sample size calculation was made for
      an effect of d = .20 with repeated measures, a power of 1- β = .80 and α = .05. Additionally
      the investigators plan to take measurements (only once) from healthy volunteers matching them
      (age and gender) with the asthma patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Actual">October 26, 2017</completion_date>
  <primary_completion_date type="Actual">October 26, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Endtidal CO2</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Capnometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Nijmegen-Score</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Questionnare assessing hyperventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Buteyko CP</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Breath hold test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spirometry: FEV1</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>FEV1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry: FEV1</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>FEV1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry: FEV1/VCin</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>FEV1/VCin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry: FEV1/VCin</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>FEV1/VCin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry: PEF</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>PEF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry: PEF</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>PEF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (SDNN)</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>SDNN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (SDNN)</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>SDNN</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (RMSSD)</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>RMSSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (RMSSD)</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>RMSSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (LF/HF)</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>LF/HF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (LF/HF)</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>LF/HF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular stiffness</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Pulse Wave Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular stiffness</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Pulse Wave Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Systolic and Diastolic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Systolic and Diastolic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Stroke volume</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Stroke volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Stroke volume</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Stroke volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Cardiac output</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Cardiac output</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Total Vascular Resistance</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Total Vascular Resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Total Vascular Resistance</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Total Vascular Resistance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Cardiac index</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Cardiac index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Cardiac index</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Cardiac index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Perfusion</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Perfusion index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Perfusion</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Perfusion index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Plethvariability</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Plethvariability index (PVI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemodynamics Plethvariability</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Plethvariability index (PVI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>SpO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>SpO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACQ</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Asthma Control Questionnaire, E. Juniper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACQ</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Asthma Control Questionnaire, E. Juniper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AQLQ</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Asthma Quality of Life Questionnaire, E. Juniper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AQLQ</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Asthma Quality of Life Questionnaire, E. Juniper</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARCIM Questionnaire</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARCIM Questionnaire</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STAI Questionnaire</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>State and Trait Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STAI Questionnaire</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>State and Trait Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ASF Questionnaire</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>&quot;Aachener Selbstwirksamkeitsfragebogen&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ASF Questionnaire</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>&quot;Aachener Selbstwirksamkeitsfragebogen&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma medication</measure>
    <time_frame>Between baseline and 3 month follow up</time_frame>
    <description>Kind and dosage of asthma specific medication like steroids or betamimetics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma medication</measure>
    <time_frame>Between baseline and 6 month follow up</time_frame>
    <description>Kind and dosage of asthma specific medication like steroids or betamimetics</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Buteyko Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breathing exercises according to the Buteyko Breathing Technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Buteyko Breathing Technique</intervention_name>
    <description>Patients are trained in various exercises aiming at breath reduction and breath control as introduced by Dr. K. Buteyko</description>
    <arm_group_label>Buteyko Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent, regular intake of prescribed asthma medication according to
             the AWMF scheme level 1, native speaker of german

        Exclusion Criteria:

          -  Participation in another study, comorbidities (heart diseases, cancer still under
             treatment, psychiatric diseases)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ARCIM Institute</name>
      <address>
        <city>Filderstadt</city>
        <state>Baden Württemberg</state>
        <zip>70794</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Buteyko-based breathing technique training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

